Contact inhibition modulates intracellular levels of miR-223 in a p27kip1-dependent manner-Reference-Cited by-同舟云学术

Contact inhibition modulates intracellular levels of miR-223 in a p27kip1-dependent manner

Published:2014-03-04 Issue:5 Volume:5 Page:1185-1197
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Armenia Joshua¹,Fabris Linda¹,Lovat Francesca²,Berton Stefania¹,Segatto Ilenia¹,D’Andrea Sara¹,Ivan Cristina³,Cascione Luciano²,Calin George A.³,Croce Carlo M.²,Colombatti Alfonso¹⁴,Vecchione Andrea²⁵,Belletti Barbara¹,Baldassarre Gustavo¹

Affiliation:

1. Division of Experimental Oncology 2, CRO, National Cancer Institute, Aviano, Italy

2. Department of Molecular Virology, Immunology and Medical Genetics and Comprehensive Cancer Center, Ohio State University, Columbus, OH, USA

3. Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, TX

4. Department of Biomedical Sciences and Technologies, MATI Center of Excellence, University of Udine, Udine, Italy

5. Division of Pathology, II University of Rome “La Sapienza”, Santo Andrea Hospital, Rome, Italy

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulation of the Cell Cycle by ncRNAs Affects the Efficiency of CDK4/6 Inhibition;International Journal of Molecular Sciences;2023-05-18

2. YB-1 Recruits Drosha to Promote Splicing of pri-miR-192 to Mediate the Proangiogenic Effects of H₂S;Antioxidants & Redox Signaling;2022-04-01

3. MicroRNAs as Potential Predictors of Response to CDK4/6 Inhibitor Treatment;Cancers;2021-08-16

4. The many facets of miR ‐223 in cancer: Oncosuppressor, oncogenic driver, therapeutic target, and biomarker of response;WIREs RNA;2021-05-05

5. Downregulation of miR-223 Expression Is an Early Event during Mammary Transformation and Confers Resistance to CDK4/6 Inhibitors in Luminal Breast Cancer;Cancer Research;2019-12-20